SA

Sara Artusi

Principal Scientist, Preclinical Development at Krystal Biotech

Sara Artusi has extensive experience in preclinical development, with a focus on developing novel viral vectors for cancer treatment. With a Ph.D. in Biomedicine from the University of Padova, Sara has also worked on innovative antiviral therapies against herpesviruses. Additionally, Sara has gained research experience in international collaborations and pharmaceutical administration during their professional internships.

Links

Org chart

Peers

PB

Patrick Bailey

Director Of Quality Assurance

RB

Rebekah Byrne

Director Of Quality Assurance

Timeline

  • Principal Scientist, Preclinical Development

    March 1, 2024 - present

  • Senior Scientist, Product Development

    March, 2021

  • Scientist, Product Development

    August, 2019

View in org chart